Okami Medical Names Bill Hykes as CEO and Closes $45M Financing

November 25, 2025—Okami Medical, Inc., a developer of vascular embolization solutions, announced that Drew Hykes was appointed President and CEO of the company, while Bill Hoffman was appointed Chairman of the Board. Hykes was CEO of Inari Medical.

The company also announced the close of an oversubscribed $45 million financing led by new investor Gilde Healthcare with participation from existing investors, including Vensana Capital and U.S. Venture Partners. As part of the financing, Geoff Pardo and Susana Amorim of Gilde Healthcare have joined Okami Medical’s Board of Directors.

Okami stated that proceeds from the financing will be used to expand the company’s commercial footprint and advance its clinical programs in the treatment of vascular disease. The funding will also support continued development of the company’s devices for the occlusion of peripheral vessels—including its low-profile braided occluder (LOBO) system

“I’m honored to join the Okami team and have been deeply impressed by the clinical performance and versatility of the LOBO vascular occluder across a wide range of anatomies,” commented Hykes in the company’s press release. “I look forward to working with this talented team to accelerate our commercial expansion, advance our innovation pipeline, and bring this important technology to more physicians and patients.”